Literature DB >> 24585865

Inflammation in pulmonary arterial hypertension: is it time to quell the fire?

Paul M Hassoun1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24585865     DOI： 10.1183/09031936.00006014

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

1.  The first annual Drug Discovery and Development Symposium for Pulmonary Hypertension.

Authors:  John H Newman
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

2.  Systemic Arterial Stiffness in New Diagnosed Idiopathic Pulmonary Arterial Hypertension Patients.

Authors:  G D Radchenko; I O Zhyvylo; E Y Titov; Yuriy M Sirenko
Journal:  Vasc Health Risk Manag       Date:  2020-01-16

3.  Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.

Authors:  Pil-Sung Yang; Dae-Hoon Kim; Yong Joon Lee; Sang-Eun Lee; Won Jun Kang; Hyuk-Jae Chang; Jeon-Soo Shin
Journal:  Respir Res       Date:  2014-11-25

4.  Intratracheal instillation of ethyl pyruvate nanoparticles prevents the development of shunt-flow-induced pulmonary arterial hypertension in a rat model.

Authors:  Kai Liu; Xiquan Zhang; Guangqing Cao; Yongjun Liu; Chuanzhen Liu; Hourong Sun; Xinyan Pang
Journal:  Int J Nanomedicine       Date:  2016-06-03

Review 5.  Effects of exercise training on pulmonary hemodynamics, functional capacity and inflammation in pulmonary hypertension.

Authors:  Manuel J Richter; Jan Grimminger; Britta Krüger; Hossein A Ghofrani; Frank C Mooren; Henning Gall; Christian Pilat; Karsten Krüger
Journal:  Pulm Circ       Date:  2017-02-01       Impact factor: 3.017

6.  Activation of PPARγ by baicalin attenuates pulmonary hypertension in an infant rat model by suppressing HMGB1/RAGE signaling.

Authors:  Zhenjie Chen; Qiuxia Wang
Journal:  FEBS Open Bio       Date:  2017-03-08       Impact factor: 2.693

7.  Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertension.

Authors:  Anna Ulrich; John Wharton; Timothy E Thayer; Emilia M Swietlik; Tufik R Assad; Ankit A Desai; Stefan Gräf; Lars Harbaum; Marc Humbert; Nicholas W Morrell; William C Nichols; Florent Soubrier; Laura Southgate; David-Alexandre Trégouët; Richard C Trembath; Evan L Brittain; Martin R Wilkins; Inga Prokopenko; Christopher J Rhodes
Journal:  Eur Respir J       Date:  2020-02-12       Impact factor: 16.671

Review 8.  Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition?

Authors:  Paulien Vinke; Suzanne M Jansen; Renger F Witkamp; Klaske van Norren
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.